Research just published in The Journal of Cell Biology reveals and important discovery about one of the most aggressive and difficult to treat forms of breast cancer. Gonzalo’s research team identified a molecular pathway in women who are born with BRCA1 gene mutations, placing them at increased risk for developing breast and ovarian cancers, frequently the triple-negative type. When this pathway is activated, tumours grow unchecked and they tend to not be sensitive to standard cancer treatments. Chemotherapy now used to treat this kind of cancer is rarely effective and carries serious side effects.
But here’s the new and hopeful news. Experiments performed in Gonzalo’s laboratory showed vitamin D was found to enable this pathway to be turned off.
In a press statement, the researchers noted they are hopeful that in the future, women with triple-negative breast cancer may benefit from a treatment that includes vitamin D.
Another study reported previously by Natural News from the University of Rochester Medical Centre found that the vast majority of women undergoing treatment for breast cancer had very low levels of vitamin D in their blood. What’s more, women whose disease had progressed to late-stage (i.e. terminal) cancer had the lowest levels of all.